Abstract
Drugs differing in their primary mechanism of action but having in common the ability to act as antidepressants such as fluoxetine (10 mg/kg SC), clomipramine (10 mg/kg IP), imipramine (10 mg/kg IP), desipramine (10 mg/kg IP) and (±)8-OHDPAT (0.03 mg/kg SC) increase extracellular concentrations of dopamine in the rat prefrontal cortex but not in the medial nucleus accumbens. Buspirone (1 mg/kg SC) increased dopamine both in the prefrontal cortex and in the nucleus accumbens. Extracellular 5HT was increased by fluoxetine, clomipramine and imipramine but not by desipramine while 8-OHDPAT and buspirone decreased it. These results raise the possibility that the property of stimulating dopamine transmission in the prefrontal cortex has a role in the antidepressant properties of these drugs.
This is a preview of subscription content, log in via an institution to check access.
References
Arborelius L, Chergui K, Murase S, Nomikos GG, Backlund Höök B, Chouvet G, Hacksell U, Svensson TH (1993) The 5HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons. Naunyn-Schmiedeberg's Arch Pharmacol 347:353–362
Baxter LR, Schwartz JM, Phelps ME, Mazziota JC, Guze BH, Selin CE, Gerner RH, Sumida RM (1989) Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46:243–254
Buchsbaum MS, Wu J, DeLisi LE, Holcomb H, Kessler R, Johnson J, King AC, Hazlett E, Langston K, Post RM (1986) Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J Affect Disord 10:137–145
Carboni E, Di Chiara G (1989) Serotonin release estimated by transcortical dialysis in freely-moving rats. Neuroscience 32:637–645
Carboni E, Tanda GL, Frau R, Di Chiara G (1990) Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem 55:1067–1070
Chen J, Paredes W, Van Praag HM, Lowinson JH, Gardner EL (1992) Presynaptic dopamine release is enhanced by 5-HT3 receptor activation in medial prefrontal cortex of freely moving rats. Synapse 10:264–266
Cimino M, Ponzio F, Achilli G, Vantini G, Perego C, Algeri S, Garattini S (1983) Dopaminergic effects of buspirone, a novel anxiolytic agent. Biochem Pharmacol 32:1069–1074
De Vry J, Schreiber R, Glaser T, Traber J (1992) Behavioral pharmacology of 5-HT1A agonists: animal models of anxiety and depression. In: Stahl SM et al (eds) Serotonin1A receptors in depression and anxiety. Raven, New York, pp 55–81
Di Chiara G, Tanda G, Frau R, Carboni E (1993) On the preferential release of dopamine in the nucleus accumbens by amphetamine: further evidence obtained by vertically implanted concentric dialysis probes. Psychopharmacology 112:398–402
Drevets WC, Videen TO, Price JL, Preskorn SH, Carmichael ST, Raichle ME (1992) A functional anatomical study of unipolar depression. J Neurosci 12:3628–3641
Imperato A, Di Chiara G (1984) Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites. J Neurosci 4:966–977
Imperato A, Di Chiara G (1985) Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by transstriatal dialysis. J Neurosci 5:297–306
Jimerson DC (1987) Role of dopamine mechanisms in the affective disorders. In: Melzer HY (ed) Psychopharmacology: the third generation of progress. Raven, New York, pp 505–511
Lemberger L, Fuller RW, Zerbe RL (1985) Use of specific serotonin uptake inhibitors as antidepressants. Clin Neuropharmacol 8:299–317
Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, New York
Pellegrino LJ, Pellegrino AS, Cushman AJ (1979) A stereotaxic atlas of the rat brain, 2nd ed. Plenum, New York
Thiebot MH, Martin P (1991) Effects of benzodiazepines, 5-HT1A agonists and 5-HT3 antagonists in animal models sensitive to antidepressant drugs. In: Rodgers RJ, Cooper SJ (eds) 5-HT1A agonists, 5-HT3 antagonists and benzodiazepines. Their comparative pharmacology. Wiley, New York, pp 159–195
Willner P (1983a) Dopamine and depression: a review of recent evidence. I. Empirical studies. Brain Res Rev 6:211–224
Willner P (1983b) Dopamine and depression: a review of recent evidence. III. The effects of antidepressant treatments. Brain Res Rev 6:237–246
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tanda, G., Carboni, E., Frau, R. et al. Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?. Psychopharmacology 115, 285–288 (1994). https://doi.org/10.1007/BF02244785
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244785